---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-307767"
form_type: "8-K"
ticker: "OGN"
cik: "0001821825"
company_name: "Organon & Co."
filed_at: "2026-07-17T20:01:17+00:00"
generated_at: "2026-07-17T20:02:05.114585+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Organon supplements proxy with $700M synergy estimate; shareholder lawsuit seeks to delay merger vote

## Summary
- Shareholder lawsuit filed July 6 in NJ Superior Court alleges proxy disclosures are materially incomplete and misleading.
- Company voluntarily supplements proxy with preliminary cost synergy estimate of ~$700M from Sun Pharma transaction.
- Provides financial projections: 2026E revenue $6,252M, Adj EBITDA $1,894M, unlevered FCF $1,010M.
- Net debt $7,530M, fully diluted shares ~284.9M as of April 24, 2026; LTM Adj EBITDA $1,832M.
- Special meeting of stockholders to vote on merger remains scheduled for July 23, 2026.

## SEC filing metadata
- accession: 0001193125-26-307767
- form_type: 8-K
- ticker: OGN
- cik: 0001821825
- company_name: Organon & Co.
- filed_at: 2026-07-17T20:01:17+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1821825/000119312526307767/0001193125-26-307767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1821825/000119312526307767/d88294d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-307767
- JSON: https://secwatch.observer/filing/0001193125-26-307767.json
- Plain text: https://secwatch.observer/filing/0001193125-26-307767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.